We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable MRI Compatible Surgical Robot Improves Patients Outcomes for Neurosurgery

By HospiMedica International staff writers
Posted on 24 May 2024

Neurosurgeons performing deep brain stimulation lead placements often encounter the challenge of brain shift, which can lead to inconsistent and suboptimal outcomes because the brain moves relative to the skull during surgery. More...

This issue results in 34% of these surgeries requiring a subsequent operation to remove or adjust the leads due to initial misplacement of the targets within the brain. Now, a compact, MRI-compatible surgical robot that facilitates intelligent intraoperative surgical planning and guidance through real-time soft tissue imaging aims to tackle the issue of brain shift during deep brain stimulation lead placements.

AiM Medical Robotics (AiM, Worcester, MA, USA) is set to launch its revolutionary stereotactic neurosurgery robot that is designed to overcome the challenges of accurate and safe intracranial placement of neuromodulation, ablation, and drug delivery devices. The AiM stereotactic neurosurgery robot enhances visualization, navigation, and control during procedures. Featuring an MRI-compatible robotic frame and integrated with cutting-edge neuro-navigation software, AiM’s system delivers exceptional precision and efficiency for deep brain interventions. By integrating intraoperative MRI guidance into routine use, AiM aims to enhance hospital efficiency, procedural consistency, and patient outcomes.

In a recent trial, AiM’s robotic system was used in a direct MRI-guided procedure for placing deep brain stimulation leads in a human cadaver, showcasing its capabilities entirely within an MRI suite. The procedure achieved high levels of efficiency and accuracy. Significantly, the trial demonstrated the system’s ability to detect and compensate for brain shifts during the operation that can affect surgical outcomes. AiM is currently preparing to conduct a new study to further validate its innovative robot for deep brain stimulation treatments in patients with Parkinson's Disease with the aim of using real-time MRI guidance for accurate placement of stimulation leads.

Related Links:
AiM Medical Robotics


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Multi-Chamber Washer-Disinfector
WD 390
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.